Physician profile
Oscar A Lopez
NPI 1669767422
$596.09
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $15.74 · 2021: $29.79 · 2022: $54.97 · 2023: $148 · 2024: $49.87 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $196.41 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $146.73 | 2019-2023 | Bridion |
| Medtronic, INC. | $120.75 | 2022-2023 | Mcgrath Mac, Nellcor |
| Mallinckrodt Enterprises LLC | $28.72 | 2019 | |
| Salvin Dental Specialties, INC. | $21.28 | 2019 | |
| Lsi Solutions INC | $19.03 | 2024 | Cor-Knot |
| Teleflex LLC | $17.20 | 2019 | |
| Molnlycke Health Care US, LLC | $16.95 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Mindray Ds USA, INC. | $15.13 | 2023 | A7 Anesthesia System |
| Pacira Pharmaceuticals Incorporated | $13.89 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.